Lithium's Risk to Fetus May Be Lower Than Previously Thought

Share this content:
Lithium's Risk to Fetus May Be Lower Than Previously Thought
Lithium's Risk to Fetus May Be Lower Than Previously Thought

THURSDAY, June 8, 2017 (HealthDay News) -- Lithium is linked to an increased risk of heart malformations in infants born to women taking the drug during pregnancy, but the risk is smaller than once believed, according to research published in the June 8 issue of the New England Journal of Medicine.

The new study included information on 1,325,563 women enrolled in Medicaid. They gave birth between 2000 and 2010. The researchers looked for incidents of infants exposed to lithium in the first trimester. They compared these babies with those exposed to lamotrigine.

The investigators observed heart malformations in 16 of the 663 infants exposed to lithium (2.41 percent). Almost 2,000 babies were exposed to lamotrigine, and 27 of those babies (1.39 percent) had a heart malformation. Just over 15,000 (1.15 percent) of the 1.3 million infants who weren't exposed to either drug had a heart malformation. The prevalence of Ebstein's anomaly was 0.60 percent among infants exposed to lithium, and 0.18 percent among unexposed infants, the researchers found.

"This association was dose dependent," lead researcher Elisabetta Patorno, M.D., Dr.P.H., an assistant professor of medicine at Harvard Medical School in Boston, told HealthDay. "In light of this new information, clinicians and patients may decide to reconsider the balance between the relatively small increase in the risk of cardiac malformations and the comparative benefits of lithium versus other mood-stabilizing strategies in deciding whether or not to prescribe and use lithium in women of reproductive age or pregnant women."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Even Overdose Doesn't Stop Opioid Prescribing

Even Overdose Doesn't Stop Opioid Prescribing

Few receive medication-assisted treatment after hospital discharge, researchers find

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

No improvement in clinical outcomes versus usual care in heart failure and reduced ejection fraction

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic Adults

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic ...

No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom

is free, fast, and customized just for you!

Already a member?

Sign In Now »